MODIFICATION TO OSI MEDICAL DOLPHIN STAND-ALONE PULSE OXIMETER AND ACCESSORIES

K012533 · Osi Medical, Inc. · DQA · Aug 22, 2001 · Cardiovascular

Device Facts

Record IDK012533
Device NameMODIFICATION TO OSI MEDICAL DOLPHIN STAND-ALONE PULSE OXIMETER AND ACCESSORIES
ApplicantOsi Medical, Inc.
Product CodeDQA · Cardiovascular
Decision DateAug 22, 2001
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.2700
Device ClassClass 2
AttributesPediatric

Intended Use

The OSI Medical Dolphin Stand-Alone Pulse Oximeter and Accessories are indicated for the continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate (measured by an SpO2 sensor). The OSI Medical Dolphin Pulse Oximeter is indicated for use with adult and pediatric patients in clinical facilities and home environments. The OSI Medical's sensor(s) are intended/indicated for use only with the OSI Medical Dolphin Stand-Alone Pulse Oximeter, and consist of the following: Digital Dolphin Disposable Sensors intended for adults / pediatrics greater than 66.14 lbs. (30kg). Digital Dolphin Reusable Sensors Intended for adults / pediatrics greater than 66.14 lbs. (30kg). Digital Dolphin 110 Extension Cable. The OSI Medical extension cable is intended/indicated for use only with the OSI Medical sensor(s) and the OS/ Medical Dolphin Stand-Alone Pulse Oximeter.

Device Story

Portable stand-alone pulse oximeter; monitors SpO2 and pulse rate. Inputs: light absorption signals from two-LED oximetry sensors via extension cable. Operation: monitor calculates ratio of oxygenated to total hemoglobin based on differential light absorption of arterial blood. Outputs: screen displays plethysmographic waveform, SpO2 value, pulse rate, alarm limits, trends, and status messages. Used in clinical facilities and home environments; operated by clinicians or patients. Healthcare providers use real-time data and alarms to assess patient oxygenation status and guide clinical interventions. Benefits: continuous, noninvasive monitoring of patient respiratory status.

Clinical Evidence

Bench testing only. Compliance with standards including ISO 9919:1992, EN 865:1997, and FDA Pulse Oximeter Guidance (1992). Biocompatibility and performance validation performed for disposable sensors.

Technological Characteristics

Portable monitor (10cm x 27.5cm x 25cm, 4kg). Power: 100-240 Vac or sealed lead-acid battery. Sensing: dual-LED optical absorption. Connectivity: wired sensor/extension cable. Standards: IEC 601-1, IEC 601-1-1, IEC 601-1-2, ISO 9919, EN 865, ASTM 1415, UL 2601-1.

Indications for Use

Indicated for continuous noninvasive monitoring of functional arterial oxygen saturation (SpO2) and pulse rate in adult and pediatric patients weighing >30kg (66.14 lbs) in clinical and home environments.

Regulatory Classification

Identification

An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K012533 AUG 2 2 2001 August 1, 2001 Summary of Safety and Effectiveness Information for the OSI Medical Dolphin Stand-Subject: Alone Pulse Oximeter and Accessories. OSI Medical Dolphin Stand-Alone Pulse Oximeter, Model No. 2100 and Accessories. Proprietary: Common: Oximeter. Oximeter Class II - 21 CFR 870.2700 - 74 DQA Classification: The 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of the SMDA 1990 and 1992. The OSI Medical Dolphin Pulse Oximeter and Accessories is substantially equivalent to the following currently marketed device(s): - OSI Medical Dolphin Stand-Alone Pulse Oximeter, Model No. 2100 and Accessories #K002036. . The OSI Medical Dolphin Pulse Oximeter and Accessories is a portable stand-alone device, connecting cable, and oximetry sensor(s) to noninvasively calculate the functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate. The monitor consists of a screen that displays the pulse plethysmographic waveform, the pulse rate, SpO2 value, the high and low SpO2 and pulse rate alarm limits, alarms, trends and status messages. It contains the electronic hardware and software that receives and calculates the signals from the LEDs within the sensor to determine the functional oxygen saturation of arterial hemoglobin (SpQz) and pulse rate, and provide for the connection to the connecting cable. The OSI Medical Dolphin Pulse Oximeter is available in one configuration as a portable stand-alone oximeter that is 10 cm / 3.94 inches high, 27.5 cm / 10.83 inches wide, 25 cm / 9.84 inches deep and weighs about 4 kg / 8.8 lbs. The unit is powered either with a voltage input of 100-240 Vac, 50-60 Hz or with a sealed lead-acid battery with an operating time of approximately 4 hours based upon 2 Ampere hour battery (200mA OEM Module, 300mA System Module) and a charge time of about 4.5 hours to 80% capacity. The extension cable connects between the monitor and oximetry sensor(s) and transfers LED drive power and the calibration drive to the oximetry sensor from the monitor receives the detector signal from the oximetry sensor. The extension cable is available in one configuration and is approximately 8 feet / 2.44m in length, and the sensor(s) are approximately 18 inches / 45.72 cm in length. The sensor(s) measure light absorption of blood from two light emitting diodes (LED's). Oxygen saturated blood absorbs light differently as compared to unsaturated blood. The amount of light absorbed by the blood is used to calculate the ratio of oxygenated hemoglobin to total hemoglobin in arterial blood. {1}------------------------------------------------ The oximetry sensor is available in a disposable or reusable configuration, and with one configuration for the extension cable (8 feet). The OSI Medical Dolphin Stand-Alone Pulse Oximeter, Model No. 2100 and Accessories have been designed to comply with the following standards: - 1. CSA C22.2 No. 601.1 - IEC 601-1. Part 1 and Amendments 1 and 2 2. - 3. IEC 601-1-1, Part 1 - 4. IEC 601-1-2, Part 1 - 5. ISO 9919: 1992 - 6. EN 865: 1997 - 7. FDA Guidance Document for Pulse Oximeters: 9/7/1992 - 8. ASTM 1415:1992, and Draft 10.1 - 9. UL2601-1: Second Edition, 1997 - 10. IEC 6068-2-6 - 11. IEC 6068-2-27 - 12. IEC 6068-2-64 - 13. ISTA Procedure 2A The OSI Medical Dolphin Stand-Alone Pulse Oximeter with disposable sensors is substantially equivalent in design concepts, technologies and materials to the OSI Medical Dolphin Stand-Alone Pulse Oximeter, with reusable sensors. Additional testing has been performed for the disposable sensors including biocompatibility and performance validation which has been included in this submission. ## 000012 {2}------------------------------------------------ Image /page/2/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a circular design with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with three heads, each head facing a different direction. AUG 2 2 2001 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Jon Werner OA Manager OSI Medical, Inc. 13801 McCormick Drive Tampa, FL 33626 Re: K012533 OSI Medical Digital Dolphin Disposable Optical Sensor, Model 510 Regulation Number: 870.2700 Regulatory Class: II (two) Product Code: 74 DQA Dated: August 3, 2001 Received: August 6, 2001 Dear Mr. Werner: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce stired in May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls Sourisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this {3}------------------------------------------------ ## Page 2 - Mr. Jon Werner response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance (DSMICA) at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, Deck Teh . Dillard III ames Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## INDICATIONS FOR INTENDED USE FOR 2100 PULSE OXIMETER K012533 510(k) Number (if known):_____________________________________________________________________________________________________________________________________________________ Device Name: OSI Medical Dolphin Stand-Alone Pulse Oximeter, Model No. 2100 August 1, 2001 Indications for Use: Indications for Use: The OSI Medical Dolphin Stand-Alone Pulse Oximeter and Accessories are indicated for the continuous The OSI Medical Dolphin Stand-Alone Califical Che Aberoglobin (SpO-) and pulse rate (measured noninvasive monitoring of lunctional oxygen saturalion of united for use with addition ase with addition and home by an SpO2 sensor). The OST Medical Dolphill Pulse Unition and Noscother Pacilities and home environments. The OSI Medical's sensor(s) are intended/indicated for use only with the OSI Medical Dolphin Stand-Alone Pulse Oximeter, and consist of the following: Digital Dolphin Disposable Sensors intended for adults / pediatrics greater than 66.14 Ibs. (30kg). Digital Dolphin Reusable Sensors Intended for adults / pediatrics greater than 66.14 Ibs. (30kg). Digital Dolphin 110 Extension Cable The OSI Medical extension cable is intended/indicated for use only with the OSI Medical sensor(s) and the OS/ Medical Dolphin Stand-Alone Pulse Oximeter. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices 510(k) Number: K012533 Prescription Use (Per 21 CFR 801.109) OR over-the-counter Use***_***_ 000009
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...